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ABSTRACT 
A FIVE-FACTOR MODEL OF PSYCHOSIS WITH THE MMPI-2-RF 
 
Jacob Warszawski, M.A. 
 
Western Carolina University (April 2018) 
 
Director: David McCord 
 
A study by Schoenbaum (2017) found that individuals undergoing first-episode psychosis are 24 
times more likely to die within a year of diagnosis than the general population. Recent research 
has found that dimensional models of psychopathology, as opposed to categorical models, yield 
better results in terms of research utility, treatment outcomes, degree of pathology, and disease 
etiology (Kotov et al., 2017). Seretti and Ogliati (2004) explored six competing dimensional 
models of psychosis and found the best fitting model to have five factors: Activation, Positive 
Symptoms, Disorganization, Depression, and Negative Symptoms. This model of psychosis 
closely resembles constructs as measured by the Minnesota Multiphasic Personality Inventory-2-
Restructured Form (MMPI-2-RF; Ben-Porath & Tellegen, 2008/2011), a structured personality 
test, and directly mirrors the constructs as measured by the Positive and Negative Syndrome 
Scale (PANSS; Kay, Opler, & Fiszbein, 1987), a structured clinical interview. This study used 
the MMPI-2-RF to elucidate the nature of psychosis, with a focus on a known population, 
individuals with psychotic disorders, in order to further understand the construct of psychosis.  
 
 
 
 
 
 
 7
CHAPTER 1: A FIVE-FACTOR MODEL OF PSYCHOSIS WITH THE MMPI-2-RF 
 
A recent study found that individuals who were diagnosed with first episode psychosis 
are at an increased risk for death in the 12 months following their diagnosis (Schoenbaum, 
2017). More specifically, these individuals had a mortality rate 24 times greater than the general 
population in the 12 months since diagnosis, with the only other group in the general population 
reaching those numbers in a 12-month period being those aged 70 and up (Schoenbaum, 2017). 
Although cause of death was not known and therefore not studied, two recent meta-analyses 
showed that individuals with psychosis are at an increased risk for suicidal ideation, planning, 
and attempt (Mcginty, Sayeed Haque, & Upthegrove, 2017; Huang, Fox, Ribeiro, and Franklin, 
2017) Furthermore, just 39% of these individuals had received antipsychotic medication, and 
only 41% received therapy of any sort. Most healthcare services accessed by these individuals 
were hospital and emergency care. The authors underscored their findings with the need for 
better assessment and treatment services for these individuals as preventative measures.  
The construct of schizophrenia was developed by German psychiatrist Emil Kraepelin, 
and first referred to as dementia praecox, or “split-mind,” to address diagnostic issues of the late 
1800’s. (Kraepelin, 1904). Since then, research has come to include a full spectrum of psychotic 
disorders. Much of the research on psychosis until the latter portion of the twentieth century 
reflected a quasi-dimensional approach, in which the “schizotype” represents a small subset of 
the population (approximately 10%) who are at-risk for a psychotic disorder with the other 90% 
not being at-risk. (Rado, 1953; Meehl, 1990; Lenzenweger, 1994; Beauchaine et al., 2008). A 
full dimensional approach, as outlined by Rawlings, Williams, Haslam, and Claridge (2008), 
posits that psychosis is a “natural central nervous system variation”, with schizophrenia and 
other disorders at the extreme, representing the functional impairment end of the spectrum, and 
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schizotypy closer to the opposite “normal” end, characterized by bizarre or eccentric appearance 
or behavior, cognitive disorganization, as well as positive and negative symptoms co-occurring 
with or without functional impairment.  
Van Os (2009) proposed completely abolishing the diagnosis of schizophrenia, 
recommending the term “salience dysregulation syndrome” as being more precisely descriptive 
of the clinical phenomena associated with this spectrum, as well as being a far less “loaded” 
(with connotations) term than schizophrenia. Salience dysregulation syndrome is comparable to 
metabolic syndrome in that a number of regulatory processes are functionally impaired and co-
occur along with other continuous risk factors. Van Os goes on to state “Many people with 
impaired glucose regulation also have several other continuous cardiovascular risk factors – they 
have a tendency to occur together . . . many people with positive psychotic experiences, that have 
been shown to constitute a fundamental alteration in salience attribution, also display evidence of 
alterations in other dimensions of psychopathology such as mania, disorganization and 
developmental cognitive deficit.” Salience dysregulation syndrome or a psychotic disorder, then, 
from a dimensional standpoint, appears to be similar to developmental disorders such as an 
intellectual disability; existing categorically in clinical settings, and on a continuum in nature.  
A review and meta-analysis by Van Os, Linscott, Myin-Germeys, Delespaul, and 
Krabbendam (2009) found the prevalence rate of dimensional psychotic phenomena was 5–8% 
in the general population, about 10 times higher than the prevalence of diagnosed psychotic 
disorders; indeed, taking into account prevalence and incidence rates, approximately 75-90% of 
psychotic experiences are transitory and fade over time. It is important to note, however, that 
while subclinical psychotic experiences are prevalent, a much smaller proportion of individuals 
will be diagnosed with a clinical psychotic disorder.   
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Van Os (1999), using regression models, found that conceptualizing psychosis as a 
dimensional construct with clinical self-report and observer report was more indicative of 
pathology than categorical conceptualization alone. Dimensional effects were cumulative: 
quality of life; social disability; satisfaction with services; abnormal movements; brief 
neuropsychological screen; and over the last 2 years – illness course, symptom severity, 
employment, medication use, self-harm, time in hospital and living independently, in addition to 
self-report measures, predicted greater dimensionality of illness. 
The need for re-evaluating how mental disorders are perceived, defined, and studied has 
been the top priority for decades, but has suffered from a lack of direction. Most recently, the 
National Institute of Mental Health implemented the Research Domain Criteria initiative 
(RDoC), a framework of conducting research that combines genetics, neuroimaging, 
physiological measures, and self-report to identify the basic structure of mental disorders. Insel 
et al. (2010) cite the failure of categorical diagnoses to match genetic findings, the inadequacy of 
the medical model to sufficiently explain underlying mechanisms of dysfunction, and the large 
amount of variance in treatment response within disorders as the primary reasons to undergo this 
radical shift in psychopathology research. Since the emergence of the RDoC, a wealth of 
research has been published exploring mental disorders from the ground up, with the most recent 
development coming from the Hierarchical Taxonomy of Psychopathology (HiToP; Kotov et al., 
2017), a departure from the common method of using DSM diagnoses or symptoms as variables 
of study, and instead focusing on an empirical framework of classifying psychopathology, using 
a hierarchical set of dimensional variables ranging from relatively broad to relatively narrow in 
scope. All psychotic disorders, including mood disorders with psychotic features and psychotic 
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personality disorders, are listed under the Thought Dysfunction domain of the HiToP. This study 
used the HiToP as a lens through which to view a well-validated model of psychosis.  
One approach in the research of psychotic symptomology is to identify 
psychopathological dimensions that cluster together more often than by chance, using factor 
analytic strategies. Individuals experiencing psychosis have historically been excluded from 
psychological studies, however, due to aggressiveness and severity of illness (Miller, Strickland, 
Davidson, & Parrott 1983). While a lack of insight is associated with psychosis (Palmer, Gilleen, 
& David, 2015), lack of insight does not necessarily impede an individual’s ability to use self-
report measures, nor participate in scientific studies (Bell et al., 2007; Lincoln et al., 2010). More 
specifically, Bell et al. (2007) found that individual with schizophrenia reliably reported on short 
rating scales in addition to long personality inventories. Lincoln et al. (2010) had similar 
findings, indicating that even lower-functioning individuals could reliably report their own 
delusions when compared to observer report.  
These factor analytic strategies initially revealed a three-factor solution (Bilder et al., 
1985; Liddle, 1992, 1987; Peralta et al., 1992) in Schizophrenia, finding positive, negative, and 
disorganized factors. The measures used in these studies did not include measures of affect, and 
studies that did include them, as in Lindenmayer et al., (2004), for example, found two additional 
factors; mania/activation and depression/depressivity. Similarly, when studying the full 
psychosis spectrum, five factors have been found across studies (Dikeos et al., 2006; Kitamura et 
al., 1995; Lindenmayer et al., 2004; McGorry et al., 1998; McIntosh et al., 2001; Murray et al., 
2005; Ratakonda et al., 1998; Serretti et al., 2001; Serretti and Olgiati, 2004; Wallwork et al., 
2015).  
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To reiterate Schoenbaum (2017), improved assessment is crucial in terms of 
understanding and treating psychosis. Current research suggests that a five-factor model of 
psychosis most effectively represents this type of dysfunction. Currently, the only instrument in 
clinical practice that assesses this five-factor model is the PANSS, which is potentially quite 
labor intensive and rarely used in clinical settings. In contrast, the MMPI instruments are the 
most widely used tools for the assessment of psychopathology. The present study is designed to 
evaluate the ability of the existing MMPI-2-RF scales to adequately assess the five-factor model. 
The potential in this study is to replicate past findings within an empirical and contemporary 
model of psychopathology, the HiToP, extend the understanding of psychosis, and possibly 
establish groundwork for more efficient assessment of psychosis. 
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CHAPTER 2: MEASURES 
MINNESOTA MULTIPHASIC PERSONALITY INVENTORY 
 The Minnesota Multiphasic Personality Inventory (MMPI) is an omnibus measure of 
psychopathology first published in 1943 by Starke Hathaway and John McKinley. The MMPI 
was originally intended to be a tool for differential diagnosis, and consisted of 10 Clinical scales 
and three Validity scales (Graham, 2012). Scale items were composed from existing measures of 
the time and contemporary models of psychopathology. Scale creation arose from “empirical 
criterion keying”, a method in which the items endorsed by a specific group were used to 
differentiate from another, non-mutually exclusive group. Due to overlapping item content and 
high scale intercorrelations, its original intended use had to be augmented by using “code-types,” 
in which the highest elevations on the test were interpreted together to form a profile.  
 Sixty-five years after the release of the original MMPI, the MMPI-2-RF (Minnesota 
Multiphasic Personality Inventory-2-Restructured Form) was released (Ben-Porath & Tellegen, 
2008/2011). In 2003, Tellegen et al. restructured the clinical scales (RC scales) to diminish the 
effects of overlapping item content between scales as well as reduce general distress variance by 
pooling a common factor among the original factors into one -  Demoralization (Ben-Porath, 
2012). The assessment model of the MMPI-2-RF is arranged hierarchically and additively, from 
relatively broad to relatively narrow in scope, and harmonizes with contemporary models of 
psychopathology. Three broad domain measures of psychopathology- Emotional Internalizing 
Dysfunction (EID), Thought Dysfunction (THD), and Behavioral Externalizing Dysfunction 
(BXD) are arranged at the top of the hierarchy, with the restructured clinical scales at the mid-
level, and specific problem scales assessing narrow facets of each domain. The Personality 
Psychopathology-Five, a parallel to the Big Five personality traits, is included within the MMPI-
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2-RF as well, and measures enduring patterns of abnormal personality characteristics (Harkness, 
McNulty, & Ben Porath, 1995).  
The scales in the Thought Dysfunction (THD) domain of the Minnesota Multiphasic 
Personality Inventory-2-Restructured Form show associations with a range of both psychotic and 
non-psychotic symptoms and traits in inpatient, outpatient, college, and general healthcare 
settings with both psychotic and non-psychotic individuals. The THD domain is a construct 
representing a broad range of psychotic experiences, and the scales within the domain, Ideas of 
Persecution (RC6), Aberrant Experiences (RC8), and Psychoticism-revised (PSYC-r) have had 
several important empirical findings.  
 Ideas of Persecution has been shown to be a valid indicator of delusions, including 
persecutory delusions, as well as ideas of reference (Arbisi et al., 2008; Handel & Archer, 2008), 
general paranoia and interpersonal mistrust (Sellbom, Graham et al., 2006), as well as alienation 
and blame externalization (Handel & Archer, 2008). Ideas of Persecution scores have been found 
to be associated with interpersonal alienation and mistrust (Tellegen & Ben-Porath, 2008) as well 
as weight related teasing in childhood (Wygant, Boutacoff et al., 2007). Ideas of Persecution is 
also correlated with broader psychotic experiences, including hallucinations and non-persecutory 
delusions (Arbisi et al., 2008; Handel & Archer, 2008; Tellegen & Ben-Porath, 2008/2011).  
 Handel and Archer (2008) found RC8 to be significantly correlated with conceptual 
disorganization, hallucinatory behavior, and unusual thought content on the Brief Psychiatric 
Rating Scale. RC8 has also been found to be significantly correlated with a diagnosis of 
Schizophrenia (Monnot et al., 2009) as well as Schizotypal Personality Disorder (Simms et al., 
2005). Dissociative experiences have also been found to be highly correlated with the RC8 scale 
and unsurprisingly, proneness to imaginative and altered states of the Absorption scale of 
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Tellegen’s (1995/2003) Multidimensional Personality Questionnaire (Tellegen & Ben-Porath, 
2008/2011).  
 High scores on the PSYC-r scale have been found to be associated with a number of 
things. First, admission problems related to psychotic symptomology and psychotic symptoms in 
mental health status examinations. In Veteran’s Administration and mental health outpatient 
samples, high PSYC-r scores were associated with measures of magical ideation and perceptual 
dysregulations. In a sample of individuals undergoing substance abuse treatment, high scores 
were associated with greater rates of hostility and depression. Finally, in a nonclinical sample, 
PSYC-r scores were associated with alienations and unusual perceptions (Ben-Porath, 2011).  
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CHAPTER 3: HYPOTHESES 
Hypothesis 1 
1: It was hypothesized that exploratory factor analysis of the MMPI-2-RF item pool (338 
individual items) from individuals diagnosed with schizophrenia would reveal five 
distinct factors, in a non-distinct order, that reflect the five factors of psychosis found in 
prior research. Furthermore, it was hypothesized that five factors would explain at least 
one-third of the variance found. Items were factor analyzed using principle axis factoring 
with direct obliminique rotation. Item content was examined and items belonging to 
existing MMPI-2-RF scales were then chosen to represent the five-factor model in 
hypothesis two. 
 
Hypothesis 2: 
To test out how existing MMPI-2-RF scales map onto a latent structure, confirmatory factor 
analyses was used in the following hypotheses.  
2a. It was hypothesized that the scales of the MMPI-2-RF identified by predominant 
factor loadings from the exploratory factor analysis will load onto a latent structure 
identified in prior research (Positive, Negative, Depressive, Activation, and Cognitive 
Disorganization).  
2b. Fit statistics will show at least adequate fit, reflecting a dimensional relationship 
between each factor and the signs and symptoms of schizophrenia.  
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CHAPTER 4: PARTICIPANTS AND PROCEDURE 
 An archival dataset collected from combined locations, one, a veteran’s administration 
medical center in Minneapolis Minnesota, and the other, the Hennepin County Medical Center, 
was used. Participants ranged in age from 18-76 years (M= 40 years, SD = 14). The sample was 
25.6% Female, 74.4% Male and predominantly caucasian (83.4% Caucasian, 11.1% African-
American, 4.6% other). Each individual from the dataset completed an MMPI-2-RF, and was 
diagnosed without test results being considered as a part of the diagnostic process, removing the 
possibility of criterion contamination. Individuals with invalid test protocols were not included in 
the study, resulting in a sample size of 2,023. Only individuals within the Thought Dysfunction 
domain of the Hierarchical Taxonomy of Psychopathology (HiToP) were included for analyses: 
schizophrenia spectrum disorders, cluster a personality disorders, and mood disorders with 
psychotic features. The final n was 698 individuals with disorders of Thought Dysfunction.  
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CHAPTER 5: ANALYSES 
To test hypothesis 1, exploratory factor analysis was used on all individuals with a 
psychotic disorder diagnosis who were retained for analysis (698), and individual MMPI-2-RF 
items were factor analyzed using principle axis factoring with direct obliminique rotation. Small 
factor coefficients, specifically those below 0.40, were suppressed. To test hypothesis 2, 
confirmatory factor analysis was conducted on each factor retained from exploratory factor 
analysis.  
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CHAPTER 6: RESULTS 
 
 Figure 1 shows the scree plot obtained from the exploratory factor analysis. See 
Appendix A for a full listing of items and factor loadings for each factor obtained from the 
exploratory factor analysis. Tables 2 and 3 show the fit indices produced from confirmatory 
factor analysis.  
 
Figure 1. Scree plot. This figure illustrates the number of factors from the exploratory factor 
analysis. 
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Factor one was comprised of items from the Emotional Internalizing Dysfunction (EID) 
domain, Demoralization (RCd), and the scales falling under it, Helplessness/Hopelessness 
(HLP), Inefficacy (NFC), Self-Doubt (SFD), and Suicidality (SUI), and additionally 
Restructured Clinical Scale 7, Dysfunctional Negative Emotions (RC7), and Shyness (SHY). 
This factor is marked by unhappiness and dissatisfaction with life, having difficulty making 
decisions, a lack of self-confidence, current or previous suicidal ideation and/or attempts, and 
feelings of helplessness and hopelessness. It is also comprised of various negative emotional 
experiences, such as fear of criticism, embarrassment, and a sense of doom, and a discomfort 
with social situations. Factor one appears to mirror the depressivity factor. RCd was chosen to 
represent this factor in the CFA. 
Factor two was comprised of items found under the EID domain, on Restructured 
Clinical Scale 2, Low Positive Emotions (RC2), Introversion-revised (INTR-r), Malaise (MLS), 
and Social Avoidance (SAV). This factor appears to reflect a lack of positive emotional 
experiences, such as anhedonia and vegetative symptoms of depression, and a tendency to 
withdraw from social situations. Furthermore, this factor is marked by extreme social 
introversion, emotional restriction, and difficulties forming close relationships. Factor two 
appears to mirror negative symptoms, specifically social anhedonia, and in some respects, such 
as items from RC2 and MLS, reflects physical anhedonia. RC2 was chosen to represent this 
factor in the CFA. 
Factor three most clearly seems to mirror the factor of positive symptoms. Factor three 
was comprised of items falling under the Thought Dysfunction (THD) domain, specifically from 
Restructured Clinical Scales 6, Ideas of Persecution (RC6), and 8, Aberrant Experiences (RC8), 
as well as Psychoticism-revised (PSYC-r) and RC7. Factor three reflects the unusual thoughts 
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and perceptions and various experiences associated with thought dysfunction, or psychosis. It is 
further comprised of items reflecting persecutory ideation, possibly including a level of paranoid 
delusions. While factor one is more saturated with various negative emotional experiences than 
factor three, it is important to note that the items on factor three reflect a fear of negative 
evaluation from strangers more so than internalization. THD was chosen to represent this factor 
in the CFA. 
Factor four was comprised of items under Restructured Clinical Scale 1 (Somatic 
Complaints) and its scales Cognitive Complaints (COG), Neurological Complaints (NUC), and 
Head Pain Complaints (HPC), and Gastrointestinal Complaints (GIC). Factor four reflects 
physical complaints and symptoms as well as cognitive difficulties, specifically problems with 
concentration, confusion, memory, and general intellectual limitations. The final piece of factor 
four is comprised of neurological and head pain complaints, specifically dizziness, unsteady gait, 
numbness, weakness, paralysis, and loss of control of movements. This factor appears to mimic 
the cognitive disorganization factor. RC1 was chosen to represent this factor in the CFA, with 
COG representing it in an alternate model. 
Lastly, factor five was comprised of items from the Behavioral Externalizing Dysfunction 
(BXD) domain, Restructured Clinical Scales 4, Antisocial Problems (RC4), 9, Hypomanic 
Activation (RC9), and Disconstraint-revised (DISC-r). This factor is marked by externalizing 
behaviors and reflects a history of antisocial behavior and family conflicts, specifically problems 
with the criminal justice system, juvenile delinquency, acting-out behaviors, and substance 
misuse. This factor is nearly equally comprised of items reflecting hypomanic activation and 
disconstrained/impulsive, acting-out behaviors, with some level of interpersonal aggressiveness, 
over self-assertiveness, and grandiosity. Factor five then appears to resemble the activation 
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factor. BXD was chosen to represent this factor in the CFA, with RC4 and RC9 chosen to 
represent in alternate models.  
 Confirmatory factor analysis results showed excellent model fit, with a chi-square of 
2.286 (p = 0.319) and all fit indices falling within an acceptable range, with the root-mean-
square-error of approximation below 0.05, and goodness-of-fit indices above .90 or .95 for 
comparative fit index. The best fitting model was composed of the following: RCd for 
depressivity, RC2 for negative symptoms, THD for positive symptoms, BXD for activation, and 
RC1 for cognitive disorganization. The alternate model’s chi-square was 7.802 (p = 0.005) and 
was composed of the following: RCd for depressivity, RC2 for negative symptoms, THD for 
positive symptoms, ACT for activation, and COG for cognitive disorganization. Table 3 shows 
the fit indices for the alternate model. 
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Figure 2. Confirmatory Factor Analysis output. This figure illustrates the output of the 
CFA best fitting model. 
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Table 1 
Confirmatory factor analysis: goodness-of-fit indices for best fitting model 
Index Five-Factor Model (WLS) 
CFI 
RMSEA 
GFI 
AGFI 
NFI 
0.99 
0.017 
0.998 
0.985 
0.997 
  
WLS = Weighted least squares; CFI = comparative fit index; RMSEA = root-mean-square-error- 
of-approximation; GFI = goodness-of-fit index; AGFI = adjusted goodness-of-fit index; NFI = 
normed fit index. 
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Figure 3. This figure illustrates the output of the alternate model for the CFA. 
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Table 2 
Confirmatory factor analysis: goodness-of-fit indices for alternate model 
Index Five-Factor Model (WLS) 
CFI 
RMSEA 
GFI 
AGFI 
NFI 
0.993 
0.054 
0.993 
0.900 
0.992 
  
WLS = Weighted least squares; CFI = comparative fit index; RMSEA = root-mean-square-error- 
of-approximation; GFI = goodness-of-fit index; AGFI = adjusted goodness-of-fit index; NFI = 
normed fit index. 
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CHAPTER 7: DISCUSSION 
 The results of the current investigation sought to replicate the five-factor model of 
psychosis, as identified in prior research, using the MMPI-2-RF. Results are in line with previous 
findings on factor models of psychosis, but not necessarily with current nosologies such as the 
HiToP, which posit that psychotic disorders strictly fall under the domain of thought 
dysfunction. Findings presented here suggest that schizophrenia is a multifactorial construct, 
with signs and symptoms falling under the somatic/cognitive, internalizing, externalizing, 
interpersonal, as well as thought dysfunction domains. One possibility, however, is that the 
factor structure of psychosis itself is not hierarchical, but heterarchical, with some symptoms 
causing others. Recent network analysis studies (Isvoranu et al., 2017; Rooijen et al., 2017) have 
found that this is in part what is happening. For example, when an individual is paranoid, that 
paranoia causes anxiety, which in turn causes activation and thus externalizing symptoms. 
Although no network analysis studies have taken place with the MMPI-2-RF and psychosis, one 
possibility of the results with this study may be that some factors are causing others to occur, 
rather than all factors being caused by the latent variable, psychosis.  
 Although the current study employed an exploratory factor analysis strategy to identify 
items and relevant scales necessary for the confirmatory factor analysis, this does not necessarily 
imply that new scales should be developed based off current results. More so, this study indicates 
that the pre-existing MMPI-2-RF item pool and existing scales adequately capture the 
symptomology of psychosis. Results from the CFA clearly indicate that RCd, RC2, THD (and its 
subscales, BXD (and its subscales, specifically ACT), and RC1 (specifically COG) map onto the 
latent structure quite well. The novel use of EFA (using only those with psychotic disorders in 
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the analysis) was necessary to identify relevant scales in the absence of another instrument to 
correlate with the MMPI-2-RF scales.  
There are several implications of this study, both in terms of research and clinical 
settings. In terms of research settings, this study further validated the five-factor model of 
psychosis using one of the most widely used personality tests, the MMPI-2-RF. Furthermore, 
while the PANSS has been used in pharmacological treatment outcomes research for nearly three 
decades, the MMPI instruments to date have not. This study provides support for the MMPI-2-
RF to be used as a pharmacological treatment outcome tool in psychosis, and future studies 
should seek to use it in such settings. For example, the MMPI-2-RF could be administered pre- 
medication and at follow-up, and changes in scale scores used as a measurement of response to 
the medication. Clinically, this study provides further support for the assessment of psychosis 
with the MMPI-2-RF. More specifically, when scales RCd, RC2, THD (or its subscales), RC1 
(or COG), and BXD (or ACT) are elevated, clinicians should be aware that this may be an 
indicator of clinical psychosis. Future studies should seek to clarify whether certain symptoms 
are causing one another (as in a network analysis), as well as possible specific cut-score 
configurations predicting psychosis severity. Limitations of this study include the use of an 
archival dataset, and the predominantly white and male comprisal of the sample. Findings 
therefore may be difficult to generalize to populations less saturated by white males. Even so, 
this study suggests that the MMPI-2-RF can capture psychotic symptomology, and at a fraction 
of the time and cost used in a structured or unstructured clinical interview. 
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Appendix A 
Items, item’s - scale membership, and factor loadings 
Factor 1 
 Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 
rf274 (RCd, NFC) 0.69     
rf48 (EID, RCd, SFD) 0.64     
rf324 (NFC) 0.63     
rf232 (RCd, SFD) 0.63    -0.46 
rf288 (RCd, SFD) 0.61     
rf198 (NFC) 0.61     
rf152 (NFC) 0.61     
rf204 (RCd) 0.61    -0.44 
rf299 (RCd) 0.61     
rf108 (NFC) 0.6     
rf331 (EID, RCd) 0.58    -0.44 
rf158 (EID, RCd) 0.57    -0.49 
rf144 (RCd) 0.56    -0.41 
rf89 (EID, RCd, SFD) 0.55    -0.44 
rf123 (STW, NEGE-r) 0.55     
rf30 (EID, RCd) 0.55    -0.45 
rf63 (RC7) 0.54   -0.42  
rf338 (K-r) 0.54    -0.44 
rf105 (EID, RCd) 0.53   0.4 0.47 
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rf29 (STW, NEGE-r) 0.53     
rf261 (EID, RCd) 0.53   -0.41 -0.51 
rf116 (NEGE-r) 0.53    -0.41 
rf228 (EID, RC7, AXY) 0.53    -0.4 
rf319 (AGGR-r) 0.53     
rf91 (EID, RC7, SHY) 0.53     
rf187 (EID, RCd, -K-r) 0.52     
rf136 (COG) 0.52    0.56 
rf149 (RC7) 0.52    -0.43 
rf322 (EID, RC7) 0.52     
rf44 (SHY) 0.52     
rf275 (RC7, AXY) 0.51  0.42  -0.44 
rf22 (EID, RCd) 0.51     
rf172 (EID, RCd) 0.51     
rf62 (RCd) 0.51     
rf335 (EID, RC7) 0.51     
rf74 (RCd) 0.51   -0.43  
rf169 (EID, HLP) 0.51     
rf6 (RCd) 0.5    -0.54 
rf247 (RCd) 0.5    -0.51 
rf68 (NFC) 0.5     
rf27 (NFC) 0.49     
rf130 (RCd) 0.49     
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rf263 (RC7, NEGE-r) 0.49     
rf315 (RCd) 0.49     
rf229 (NFC) 0.49     
rf112 (RC7) 0.48     
rf167 (EID, STW, NEGE-r) 0.48     
rf250 (EID, RC7) 0.47    -0.43 
rf318 (RC7, ANP) 0.46     
rf235 (RC7) 0.46  0.47   
rf77 (RC7, NEGE-r) 0.45     
rf35 (EID, RC7, SHY) 0.45     
rf40 (PSYC-r) 0.45     
rf177 (SHY) 0.45     
rf117 (RCd) 0.45    -0.46 
rf24 (IPP) 0.44     
rf51 (RC7) 0.44  0.42   
rf119 (EID, RC7, ANP) 0.44     
rf135 (HLP) 0.43     
rf217 (EID, RCd) 0.43    -0.4 
rf132 (RC7) 0.43     
rf120 (EID, SUI) 0.42    -0.42 
rf206 (RC7, NEGE-r) 0.41     
rf103 (FML) 0.41     
rf334 (SUI) 0.41     
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rf18 (MLS, -MSF) 0.41    -0.52 
rf336 (HLP) 0.41     
rf114 (EID, SHY) 0.41     
rf282 (EID, RC2, HLP) -0.4     
rf182 (AGGR-r, -RC2) -0.4     
rf95 (L-r) -0.41 0.42    
rf4(EID, RC2, MLS, INTR-
r) 
-0.41 0.43   0.41 
rf293 (EID, ANP, NEGE-r) -0.42    0.46 
rf37 (EID, NEGE-r) -0.45     
 
Factor 2 
 Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 
rf201 (SAV, INTR-r)  0.63    
rf57 (EID, SAV, INTR-
r) 
 0.61    
rf109 (SAV, INTR-r)  0.59    
rf17 (EID, RC2, SAV, 
INTR-r) 
 0.5    
rf140 (EID, RC2, INTR-
r) 
 0.5    
rf11 (SAV, INTR-r)  0.49    
rf47 (RC9, -SAV,  0.48    
 
 41
INTR-r) 
rf153 (SAV, INTR-r)  0.48    
rf323 (RC2, INTR-r)  0.47    
rf64 (EID, RC2, INTR-
r) 
 0.47    
rf195 (RC2, INTR-r)  0.46    
rf94 (SAV)  0.44    
rf4(EID, RC2, MLS, 
INTR-r) 
-0.41 0.43   0.41 
rf95 (L-r) -0.41 0.42    
rf278 (SAV)  0.41    
rf222 (EID, RC2, SAV, 
INTR-r) 
 0.41    
rf67 (DSF)  -0.47    
 
Factor 3 
 Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 
rf168 (THD, RC6, 
PSYC-r) 
  0.63   
rf92 (THD, RC6, 
PSYC-r) 
  0.62   
rf252 (THD, RC6, 
PSYC-r) 
  0.62   
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rf273 (THD, RC8)   0.6   
rf287 (THD, RC6, 
PSYC-r) 
  0.58   
rf330 (THD, RC8, 
PSYC-r) 
  0.57   
rf264 (THD, RC6, 
PSYC-r) 
  0.57   
rf46 (THD, RC8, 
PSYC-r) 
  0.57   
rf139 (THD, RC8, 
PSYC-r) 
  0.56   
rf270 (THD, RC6, 
PSYC-r) 
  0.56   
rf294 (THD, RC8, 
PSYC-r) 
  0.55   
rf332 (THD, RC6, 
PSYC-r) 
  0.55   
rf71 (THD, RC6, 
PSYC-r) 
  0.54   
rf233 (RC6)   0.54   
rf129 (THD, RC6, 
PSYC-r) 
  0.52   
rf203 (THD, RC8,   0.51   
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PSYC-r) 
rf14 (THD, RC6, 
PSYC-r) 
  0.51   
rf161 (RC7)   0.5   
rf199 (THD, RC8, 
PSYC-r) 
  0.5   
rf216 (THD, RC8, 
PSYC-r) 
  0.49   
rf240 (RC8, COG, 
PSYC-r) 
  0.48   
rf150 (THD, RC6, 
PSYC-r) 
  0.47   
rf34 (RC6, PSYC-r)   0.47   
rf235 (RC7) 0.46  0.47   
rf310 (RC6)   0.45   
rf257 (RC8, COG)   0.45   
rf311 (THD, RC8, 
PSYC-r) 
  0.44   
rf178 (Fp-r)   0.44   
rf194 (RC6)   0.44   
rf317 (Fp-r, BRF)   0.44   
rf133   0.43   
rf110 (THD, RC6)   0.43   
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rf191 (Fp-r)   0.43   
rf314 (Fp-r)   0.43   
rf122 (THD, RC8, 
NUC) 
  0.42   
rf275 (RC7, AXY) 0.51  0.42  -0.44 
rf146 (RC7, AXY, 
NEGE-r) 
  0.42   
rf51 (RC7) 0.44  0.42   
rf12 (THD, RC8, 
PSYC-r) 
  0.41   
rf307 (FML)   0.41   
rf208 (Fp-r, BRF)   0.4   
 
Factor 4 
 Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 
rf223 (BXD, RC4, 
JCP, DISC-r) 
   0.52   
rf49 (BXD, RC4, 
SUB, DISC-r) 
   0.51   
rf66 (BXD, RC4, 
JCP, DISC-r) 
   0.51   
rf266 (BXD, RC4, 
SUB) 
   0.5   
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rf141 (RC4, SUB)    0.5   
rf237 (BXD, RC4, 
SUB, DISC-r) 
   0.49   
rf21 (BXD, RC4, 
JCP, DISC-r) 
   0.48   
rf297 (RC4, SUB, 
DISC-r) 
   0.47   
rf93 (SUI)    0.45   
rf84 (BXD, RC9, 
AGG, AGGR-r) 
   0.45  0.41 
rf193 (BXD, RC9, 
DISC-r) 
   0.44   
rf5 (RC4)    0.44   
rf312 (BXD, RC4, 
AGG) 
   0.43   
rf26 (RC9, AGG, 
AGGR-r) 
   0.43   
rf329 (BXD, RC4, 
AGG, AGGR-r) 
   0.42   
rf105 (EID, RCd) 0.53   0.4 0.47  
rf164 (SUI)    -0.41   
rf261 (EID, RCd) 0.53   -0.41 -0.51  
rf63 (RC7) 0.54   -0.42   
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rf45    -0.43   
rf74 (RCd) 0.51   -0.43   
rf23 (RC7, AGG, 
NEGE-r) 
   -0.47   
 
Factor 5 
 Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 
rf265 (RC1, HPC)     0.6 
rf136 (COG) 0.52    0.56 
rf227 (RC1, NUC)     0.56 
rf101 (RC1, HPC)     0.56 
rf59 (COG)     0.55 
rf176 (RC1, HPC)     0.55 
rf174 (RC1, MLS)     0.52 
rf76 (RC1, GIC)     0.51 
rf200 (COG)     0.51 
rf88 (RC1, HPC)     0.51 
rf210 (GIC)     0.51 
rf189 (RC1, HPC)     0.5 
rf254 (RC1)     0.49 
rf25 (EID, RC2, 
MLS) 
    0.49 
rf280 (COG)     0.49 
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rf301 (RC1, NUC)     0.48 
rf162 (RC1, NUC)     0.48 
rf262 (MLS)     0.48 
rf277 (RC1, NUC, 
NEGE-r) 
    0.48 
rf105 (EID, RCd) 0.53   0.4 0.47 
rf73 (EID, STW, 
NEGE-r) 
    0.47 
rf113 (RC1, NUC)     0.47 
rf333 (MLS)     0.47 
rf293 (EID, ANP, 
NEGE-r) 
-0.42    0.46 
rf31 (COG)     0.46 
rf163 (MLS)     0.45 
rf328 (RC1, HPC)     0.45 
rf125 (RC1, NUC)     0.44 
rf242 (RC1)     0.44 
rf230 (RC1, GIC)     0.44 
rf69 (RC1, NUC)     0.43 
rf15 (RC1)     0.43 
rf306 (COG)     0.42 
rf4(EID, RC2, MLS, 
INTR-r) 
-0.41 0.43   0.41 
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rf228 (EID, RC7, 
AXY) 
0.53    -0.4 
rf217 (EID, RCd) 0.43    -0.4 
rf144 (RCd) 0.56    -0.41 
rf116 (NEGE-r) 0.53    -0.41 
rf120 (EID, SUI) 0.42    -0.42 
rf149 (RC7) 0.52    -0.43 
rf250 (EID, RC7) 0.47    -0.43 
rf79 (AXY)     -0.43 
rf204 (RCd) 0.61    -0.44 
rf89 (EID, RCd, SFD) 0.55    -0.44 
rf275 (RC7, AXY) 0.51  0.42  -0.44 
rf338 (K-r) 0.54    -0.44 
rf331 (EID, RCd) 0.58    -0.44 
rf289 (RC7, AXY)     -0.44 
rf30 (EID, RCd) 0.55    -0.45 
rf232 (RCd, SFD) 0.63    -0.46 
rf117 (RCd) 0.45    -0.46 
rf159 (RC8, COG)     -0.48 
rf158 (EID, RCd) 0.57    -0.49 
rf261 (EID, RCd) 0.53   -0.41 -0.51 
rf247 (RCd) 0.5    -0.51 
rf18 (MLS, -MSF) 0.41    -0.52 
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rf6 (RCd) 0.5    -0.54 
 
Factor 6 
 Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 
rf260 (RC3)      0.48 
rf256 (RC9, AGGR-r)      0.48 
rf316 (BXD, RC9, 
AGG, AGGR-r) 
     0.48 
rf36 (RC3)      0.47 
rf327 (RC9, AGGR-r)      0.45 
rf83 (EID, RC2)      0.44 
rf248 (BXD, RC9, 
ANP) 
     0.43 
rf99 (RC3)      0.43 
rf84 (BXD, RC9, 
AGG, AGGR-r) 
   0.45  0.41 
rf321 (AGGR-r)      0.41 
 
 
